Sulfacetamide Sodium Ophthalmic Solution 10%

BLEPH®-10 (sulfacetamide sodium ophthalmic solution 10%) (sulfacetamide sodium ophthalmic solution, USP) 10% is supplied sterile in opaque white LDPE plastic bottles and white dropper tips with white high impact polystyrene (HIPS) caps as follows:

5 mL in 10mL bottle.....................NDC 11980-011-05

Note: Store at 8°-25°C (46°-77°F). Protect from light. Sulfonamide solutions, on long standing, will darken in color and should be discarded.

Revised February 2005. Allergan, Inc. Irvine, CA 92714, U.S.A. FDA Rev date: 11/15/2002

No information provided.

To avoid contamination, do not touch tip of container to the eye, eyelid or any surface.

Bacterial and fungal corneal ulcers have developed during treatment with sulfonamide ophthalmic preparations.

The most frequently reported reactions are local irritation, stinging and burning. Less commonly reported reactions include non-specific conjunctivitis, conjunctival hyperemia, secondary infections and allergic reactions.

Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias (see WARNINGS).

Read the entire FDA prescribing information for Bleph (Sulfacetamide Sodium Ophthalmic Solution 10%)

• Pred Forte

Read the Bleph User Reviews »

© Bleph Patient Information is supplied by Cerner Multum, Inc. and Bleph Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.